Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 07/17/2026 | PUT | $110.00 | 11,830 | +11,830 | |
| 07/17/2026 | CALL | $110.00 | 11,830 | +11,830 | |
| 10/16/2026 | CALL | $130.00 | 2,138 | +1,555 | +266.72% |
| 06/18/2026 | CALL | $120.00 | 9,663 | +1,224 | +14.50% |
| 05/15/2026 | CALL | $111.00 | 730 | +507 | +227.35% |
| 05/15/2026 | PUT | $113.00 | 1,818 | +399 | +28.12% |
| 05/08/2026 | PUT | $118.00 | 113 | -63 | -35.80% |
| 05/08/2026 | CALL | $117.00 | 664 | -80 | -10.75% |
| 05/15/2026 | PUT | $120.00 | 8,620 | -3,830 | -30.76% |
| 05/15/2026 | CALL | $120.00 | 8,620 | -3,830 | -30.76% |
| 05/15/2026 | CALL | $115.00 | 4,522 | -7,000 | -60.75% |
| 05/15/2026 | PUT | $115.00 | 4,500 | -7,000 | -60.87% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.94% | 74.47M | 6.53B |
| Vanguard 500 Index Fund | 2.21% | 55.97M | 4.91B |
| SPDR S&P 500 ETF Trust | 1.07% | 27.12M | 2.38B |
| Fidelity 500 Index Fund | 1.06% | 26.84M | 2.35B |
| iShares Core S&P 500 ETF | 0.88% | 22.4M | 1.96B |
| Vanguard Index-Value Index Fund | 0.86% | 21.87M | 1.92B |
| Select Sector SPDR Fund-Health Care | 0.80% | 20.27M | 1.78B |
| Vanguard Institutional Index Fund-Institutional Index Fund | 0.74% | 18.74M | 1.64B |
| Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF | 0.72% | 18.33M | 1.61B |
| Vanguard Fenway Funds-Equity Income Fund | 0.55% | 13.84M | 1.21B |
| Vanguard Specialized-Dividend Growth Fund | 0.50% | 12.76M | 1.12B |
| MFS Series Trust I-MFS Value Fund | 0.48% | 12.13M | 1.06B |
| Columbia Fds Ser Tr I-Columbia Dividend Income Fd | 0.33% | 8.45M | 741.3M |
| Income Fund of America Inc | 0.28% | 7.05M | 618.18M |
| Vanguard/Wellesley Income Fund | 0.28% | 7.12M | 624.65M |
| Schwab Capital Trust-Schwab S&P 500 Index Fund | 0.18% | 4.58M | 401.42M |
| Franklin Custodian Funds-Income Fund | 0.18% | 4.5M | 394.74M |
| Invesco Diversified Dividend Fund | 0.17% | 4.33M | 379.45M |
2 Dividend Stocks to Double Up On Right Now
05/08 01:30 pm
The Motley Fool
Read moreImmutrin appoints leading cardiovascular drug development expert Dr. Robert Blaustein as Chief Medical Officer and establishes US subsidiary
05/06 07:00 am
GlobeNewswire Inc.
Read moreInVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics
05/01 08:00 am
GlobeNewswire Inc.
Read moreMerck Swings To Quarterly Loss On Cidara Deal
04/30 01:10 pm
Benzinga
Read moreBulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - Analyst Recommendations and Global Forecast to 2031
04/28 10:00 am
GlobeNewswire Inc.
Read moreAntibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence
04/28 03:52 am
GlobeNewswire Inc.
Read moreAI Disruption in Lung Cancer Therapeutics Set to Transform Treatment Paradigms as Billion-Dollar Investments Drive Innovation
04/27 01:36 pm
GlobeNewswire Inc.
Read morePeripheral T-Cell Lymphoma Market to Witness Significant Expansion at a CAGR of 7% During the Forecast Period (2026–2036) Amid Advancing Treatment Landscape | DelveInsight
04/27 01:00 pm
GlobeNewswire Inc.
Read more3 Biotech Stocks That Could Benefit from the Patent Cliff
04/27 11:29 am
Investing.com
Read moreMental Health Clinical Trials Research Report 2026: $4.89 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
04/24 04:57 am
GlobeNewswire Inc.
Read moreLarge Drugmakers Eye Inhibrx Cancer Drugs Valued Over $8 Billion, Stock Surges
04/22 02:20 pm
Benzinga
Read morePolycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight
04/22 01:00 pm
GlobeNewswire Inc.
Read moreVulvar Cancer Market Global and Regional Analysis Report 2025-2035, Profiles of Merck & Co., Bristol Myers Squibb, and AstraZeneca
04/22 05:59 am
GlobeNewswire Inc.
Read moreWhy Is Merck Stock Falling Tuesday?
04/21 01:42 pm
Benzinga
Read moreFollicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight
04/21 01:00 pm
GlobeNewswire Inc.
Read moreOncolytic Virus Immunotherapy Market Landscape Report 2026: A $5 Opportunity by 2031 - Technology Platforms, Approved Therapy Dosage, Price & Clinical Trials Insights
04/21 04:14 am
GlobeNewswire Inc.
Read morePheochromocytoma and Paraganglioma Market to Exhibit Growth at 7.3% CAGR by 2036 Driven by the Advent of Drug Classes Such as SSTR2 analogs, Dopamine Receptor D2 Agonists, TAAs or TSAs, and Others | DelveInsight
04/20 01:00 pm
GlobeNewswire Inc.
Read moreBetter Pharma Dividend Stock: Novartis vs. Merck
04/17 02:37 pm
The Motley Fool
Read moreNon-Small Cell Lung Cancer Clinical Trial Race Intensifies as 100+ Companies Competing in Therapeutic Segment Worldwide | DelveInsight
04/16 01:00 pm
GlobeNewswire Inc.
Read moreImmutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma
04/15 08:00 am
GlobeNewswire Inc.
Read moreMestag Therapeutics Selected to Present Targeted LTBR Agonist MST‑0312 in Late‑Breaking Session at AACR Annual Meeting
04/14 03:30 am
GlobeNewswire Inc.
Read moreRevolution Medicines Rallies After Phase 3 Pancreatic Cancer Trial Doubles Survival Versus Chemo
04/13 10:10 am
Benzinga
Read more$5.14 Bn Castration-sensitive Prostate Cancer Market Insights, Epidemiology, and Forecasts, 2022-2026 & 2026-2036
04/13 04:44 am
GlobeNewswire Inc.
Read moreEpitopea renforce son comité consultatif scientifique avec la nomination de Lisa Butterfield, figure de renom dans le domaine du cancer
04/13 04:00 am
GlobeNewswire Inc.
Read moreWhich Dividend Pharma Stock Should a Value Investor Choose Today?
04/12 08:28 pm
The Motley Fool
Read moreSun Pharma Nears Final Offer For Organon In Largest Overseas Bet
04/10 10:57 am
Benzinga
Read moreCrohn's Disease Eight-Market Drug Forecast and Market Analysis Report 2025-2026: Novel MOAs Will Provide Market Shifts Throughout the Forecast Period to 2032
04/10 04:43 am
GlobeNewswire Inc.
Read moreMerck Lowered Terns Pharmaceuticals Offer Price After Trial Data Review
04/07 02:28 pm
Benzinga
Read moreWhat's Going On With Merck Stock Tuesday?
04/07 12:46 pm
Benzinga
Read moreEvaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
04/07 08:00 am
GlobeNewswire Inc.
Read moreMerck Just Made a Big Bet on a New Cancer Growth Engine
04/02 11:32 am
Investing.com
Read moreAdagene Reports Full Year 2025 Financial Results and Provides Corporate Update
04/01 05:00 pm
GlobeNewswire Inc.
Read moreMerck Locks Infinimmune Alliance To Chase Next-Gen Antibody Drugs
04/01 09:26 am
Benzinga
Read moreThis Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
03/30 06:30 am
The Motley Fool
Read moreEsophageal Cancer Market to Grow from $1.65 Billion in 2026 to $2.37 Billion by 2030: Pfizer, Roche, Merck & Co. Dominate
03/30 05:00 am
GlobeNewswire Inc.
Read moreMerck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst
03/25 11:20 am
Benzinga
Read moreMerck to Acquire Terns Pharmaceuticals, Inc., Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia (CML)
03/25 06:48 am
Benzinga
Read moreMerck Nears $6 Billion Deal To Buy Terns Pharma: Report
03/25 05:38 am
Benzinga
Read moreQuotient Therapeutics Announces Collaboration with Merck to Discover Novel Drug Targets in Inflammatory Bowel Disease Using Somatic Genomics Platform Technology
03/24 06:00 am
GlobeNewswire Inc.
Read moreELISpot & FluoroSpot Assay Market Report 2026-2031: Mabtech, Oxford Immunotec Global, and Cellular Technology Dominate the Landscape
03/20 07:00 am
GlobeNewswire Inc.
Read morePfizer vs Moderna: Which Pharma Stock Has More Upside?
03/19 03:30 pm
The Motley Fool
Read moreUnnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
03/16 07:00 am
GlobeNewswire Inc.
Read moreZostavax Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
03/09 10:59 am
GlobeNewswire Inc.
Read moreRotateq Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
03/09 10:54 am
GlobeNewswire Inc.
Read more1 Dividend Stock to Buy Hand Over Fist and 1 to Avoid
03/08 01:30 pm
The Motley Fool
Read moreCytokines Market Global Forecast 2026-2032: Precise Treatments, Strategic Partnerships, and Supply Chain Resilience Fueling the $95+ Billion Market
03/05 05:44 am
GlobeNewswire Inc.
Read moreAI-Powered Tempus Inks New Multi-Year Merck Deal
03/03 03:33 pm
Benzinga
Read moreMXene Industry Research Report 2026: Market to Grow at a CAGR of 35.6% to 2032, Driven by EV & Charging Infrastructure, Water Treatment Applications and High-Performance Aerospace & Defense Systems
03/03 05:53 am
GlobeNewswire Inc.
Read moreAntibiotics Market - 4.07% CAGR Forecast for 2026-2031 as Antimicrobial Innovation Strengthens Demand, Says Mordor Intelligence
03/02 05:59 am
GlobeNewswire Inc.
Read more